You searched for "retinopathy"
Retinal ischaemia on OCTA and diabetic retinopathy grade
1 April 2020
| Saruban Pasu
|
Retina / Uvea / Vitreous
The authors quite rightly point out that quantification of retinal ischaemia has the potential to serve as a biomarker for diabetic retinopathy disease progression. They set out to investigate the relationship between area of ischaemia on a swept source OCTA...
Is myopia protective against progression of diabetic retinopathy?
2 December 2019
| Tasmin Berman
|
Retina / Uvea / Vitreous
This population-based cohort study assessed the association of refractive error with the incidence and progression of diabetic retinopathy (DR); 1562 eyes of 860 patients with diabetes and gradable retinal photographs were included. Baseline data was taken between 2004-2009 and follow-up...
Akimba mice, a model of human diabetic retinopathy
1 October 2014
| Graham Wallace
|
Retina / Uvea / Vitreous
|
Akimba, BRB, PLVAP, blood-retinal barrier, diabetic macular edema, diabetic retinopathy, mouse models, retina
Diabetic retinopathy (DR) is a major complication of diabetes and a growing problem as the systemic disease becomes more prevalent. DR develops insidiously from an asymptomatic form through to vascular damage that leads to oedema and breakdown of the blood-retinal...
Hyper reflective foci (HRF) on OCT in diabetic retinopathy
1 April 2015
| Saruban Pasu
|
Retina / Uvea / Vitreous
This study investigated the presence of hyper reflective foci (HRF) in asymptomatic patients affected by type 1 or type 2 diabetes, separately, without clinically significant diabetic macular oedema and visual impairment. In total 71 eyes with non-proliferative diabetic retinopathy were...
Outcomes of reinjection of Ranibizumab for reactivation of retinopathy of prematurity
5 June 2023
| Ivan Yip
|
Paediatric Ophthalmology / Strabismus
The authors present their data from Egypt assessing the effects of Ranibizumab reinjection for neonates with retinopathy of prematurity (ROP). Doses given were 0.25mg/0.025mL. They screened 2318 infants with 115 (5%) of infants with a mean post menstrual age (PMA)...
Collaborating across the Caribbean to tackle diabetic retinopathy
1 December 2017
| Pippa Williams, Melissa Bailey, Covadonga Bascaran, Marcia Zondervan
|
AMD, Emergency Ophthalmology, EYE - Vitreo-Retinal
The VISION 2020 LINKS Programme has been running since 2004, with a focus on improving the quality and quantity of eye care training in low-income countries [1]. In 2014, the Diabetic Retinopathy Network (DR-NET) was established [2]. This is a...
Launch of the Diabetic Retinopathy Screening Service in UHWI Jamaica
1 June 2016
| Lizette Mowatt, Peter Mitchell, Tunde Peto, Marcia Zondervan
|
EYE - Vitreo-Retinal
At 2.55pm on Wednesday 16 March 2016 the first patient was screened and given her results in the new nurse-led Diabetic Retinopathy Screening (DRS) Clinic at the University Hospital of the West Indies (UHWI), Kingston, Jamaica. This was the result...
Building capacity for diabetic retinopathy services in Malawi
1 August 2019
| Roxanne Annoh, Joseph Msosa, Caroline Styles, Moira Gandiwa, Anne Sinclair, Marcia Zondervan
|
Ophthalmology, EYE - Vitreo-Retinal
Screening for diabetic retinopathy prevents blindness. There is no systematic screening programme for diabetic eye disease in Malawi and people present when they have lost vision and it is too late for treatment. The aim of the VISION 2020 LINK...
ANGPTL-4 inhibition reduces inflammation in diabetic retinopathy
1 June 2018
| Graham Wallace
|
Retina / Uvea / Vitreous
|
Adipocytokine, Angiopoietin-like protein-4 (ANGPTL-4), Diabetic retinopathy (DR), Hypoxia inducible factor-1 alpha (HIF-1α), Inflammation, Profilin-1
Diabetic retinopathy (DR) is the most common cause of blindness in working-age humans, and numbers are rising due to increased cases of type 2 diabetes (T2D). T2D is associated with increased obesity and dyslipidaemia, which is a major risk factor...
Diabetic Retinopathy Network laser training programme
5 February 2020
| Nick Astbury, Denise Mabey, Joachim Kilemile, William Makupa, Marcia Zondervan
|
Ophthalmology, EYE - Vitreo-Retinal
The VISION 2020 Diabetic Retinopathy Network (DR-NET) was established in 2014 to tackle the increasing burden of diabetes and diabetic retinopathy (DR) in developing countries [1]. By forming a network of long-term LINK capacity-building partnerships, learning and best practice can...
Situation analysis of diabetic retinopathy services in eleven countries
1 December 2015
| Peter Blows, Tunde Peto, Heiko Philippin, Marcia Zondervan
|
AMD, Emergency Ophthalmology, Genetics, Ophthalmology, Optometry, EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
A five-year project funded by The Queen Elizabeth Diamond Jubilee Trust is facilitating development of diabetic retinopathy services (DRS) to reduce unnecessary blindness in 10 Commonwealth countries through the establishment of a capacity-building network, the DR-NET part of the Commonwealth...
Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network
1 February 2017
| Nick Astbury, Philip Burgess, Allen Foster (Prof), Denise Mabey, Marcia Zondervan
|
Genetics, Ophthalmology, Optometry, AMD, Emergency Ophthalmology, EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...